Skip to main content
Log in

N-Acetylcysteine (NAC)-Induced Hyponatremia Caused by an Electronic Medical Record (EMR) Order Error

  • Toxicology Observation
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

Intravenous N-acetylcysteine (NAC) causes few adverse drug events, with mild anaphylactoid reactions being the most common. Hyponatremia as a complication of hypoosmolar NAC solution has been reported. We describe how a locally constructed electronic medical record (EMR) order set for IV NAC resulted in a seizure from hyponatremia due to excess free water administration.

Case Report

A 13-month-old female with no past medical history presented to a hospital after ingesting an unknown number of acetaminophen 500 mg tablets. The 4-h acetaminophen concentration was 343 mcg/mL, and she was started on IV NAC. 8.2 h into her 21-h IV NAC protocol, she developed a tonic-clonic seizure. Repeat serum sodium was 124 mEq/L, a decrease from 142 mEq/L at the time of admission. She was treated with hypertonic saline, lorazepam, and levetiracetam and had no further seizures. A brain MRI and EEG were both normal. After the seizure was stabilized, the providers noticed that the patient had receive a total of 900 mL of D5W (112.5 mL/kg) in the first 9 h of hospitalization. This was caused by a poorly constructed, restrictive, EMR order set that did not allow customization of the IV NAC preparation.

Discussion

Because the 21-h IV NAC administration involves preparation of 3 different doses infused over 3 different time intervals, an order set was developed to reduce ordering errors. However, error in its construction caused the pharmacist to prepare a solution containing too much free water, decreasing patient’s intravascular sodium and resulting in a seizure.

Conclusion

The purposes of our case report were to highlight the dangers of overreliance on EMR order sets and to recognize hyponatremic seizures as an adverse reaction of an inappropriately prepared IV NAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sandilands EA, Bateman DN (2009) Adverse reactions associated with acetylcysteine. Clin Toxicol 47(2):81–8

    Article  CAS  Google Scholar 

  2. Bailey B, Blais R, Letarte A (2004) Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med 44(4):401–6

    Article  PubMed  Google Scholar 

  3. Acetadote (acetylcysteine) Injection Initial U.S. Approval: 2004. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021539s012lbl.pdf. Accessed 21 Dec 2013.

  4. Hayes BD, Klein-Schwartz W, Doyon S (2008) Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 42(6):766–70

    Article  CAS  PubMed  Google Scholar 

  5. Sung L, Simons JA, Dayneka NL, PharmD P (1997) Dilution of Intravenous N-Acetylcysteine as a Cause of Hyponatremia. Pediatrics 100(3):389

    Article  CAS  PubMed  Google Scholar 

  6. Mayordomo-Colunga J, Larrea E, García M, Suárez S, Rodríguez J (2009) Life-threatening hyponatremia due to intravenous n-acetylcysteine treatment in an infant: a case report. Cases J 2(1):8347

    Article  PubMed Central  PubMed  Google Scholar 

  7. Johnson MT, McCammon CA, Mullins ME, Halcomb SE (2011) Evaluation of a simplified N-acetylcysteine dosing regimen for the treatment of acetaminophen toxicity. Ann Pharmacother 45(6):713–20

    Article  CAS  PubMed  Google Scholar 

  8. Abramson EL, Malhotra S, Osorio SN et al (2013) A long-term follow-up evaluation of electronic health record prescribing safety. J Am Med Inform Assoc 20(e1):e52–8

    Article  PubMed Central  PubMed  Google Scholar 

  9. Anderson JG, Jay SJ, Anderson M, Hunt TJ (2002) Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach. J Am Med Inform Assoc 9(5):479–90

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jakub Furmaga.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furmaga, J., Wax, P. & Kleinschmidt, K. N-Acetylcysteine (NAC)-Induced Hyponatremia Caused by an Electronic Medical Record (EMR) Order Error. J. Med. Toxicol. 11, 355–358 (2015). https://doi.org/10.1007/s13181-015-0461-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-015-0461-4

Keywords

Navigation